Engineer, Evaluate, and Manufacture.
The AVATAR platform brings physiologically relevant tumor microenvironment (TME) control
into cell therapy workflows, improving potency, persistence, and predictability for solid tumor therapies.
Microenvironment-Driven Manufacturing.
Integrate physiologic oxygen and pressure control directly into GMP workflows to train cells for environments they face in vivo.
Seamless R&D → GMP Continuity.
Our platforms share identical environmental profiles and formats, reducing technical transfer risk and accelerating translation.
Closed, Automated Scale-Up.
Reproducible yields and consistent phenotypes supported by closed, automated workflows designed for manufacturing.
TME-Informed Potency Insights.
Generate real-time, label-free potency data under physiologically relevant conditions to inform faster, more predictive decisions.
From Discovery to Clinical Manufacturing
A single, continuous platform designed to optimize cell therapy potency at every stage offering development
Functional Evaluation
Validated by Leaders in Cell & Gene Therapy
Setting a new standard for solid tumor cell therapy development.
The Phenotype That Persists
Selective expansion of Tcm and Tscm populations associated with efficacy.
Sustained Killing Power
Persistent cytotoxicity through repeated tumor challenges under harsh TME conditions easy.
Built for Existing GMP workflow
Drop-in compatibility enables faster deployment with lower infrastructure costs.
White Paper
Unlocking organoid potential through improved culture conditions
Yelena Bronevetsky
September 2025
Publication
PHPT1 acts as an inhibitor in high-altitude pulmonary hypertension via negative TRPV5 signaling regulation
Journal of Translational Medicine (2025)
News
To Bring Cell Culture into the Future, Consider Microenvironments
James Lim
December 2025
Ready To Transform Your Cell Therapy Development?
Use AVATAR to develop the next generation of effective solid tumor therapies.